Form 4 Filing for Immunovant, Inc. - Officer Stock Transaction

This Form 4 filing details a transaction by Christopher Van Tuyl, Chief Legal Officer of Immunovant, Inc. On April 8, 2026, Van Tuyl sold 5,165 shares of common stock at a weighted average price of $24.83 per share (ranging from $24.54 to $25.39). This sale was conducted to cover tax withholding obligations stemming from the vesting of 12,696 restricted stock units (RSUs) that were granted on April 1, 2025. The sale was mandated by the company's policy to cover such taxes through a "sell to cover" mechanism, and it does not represent a discretionary sale. Following this transaction, Van Tuyl holds 183,231 shares of Immunovant common stock.